Properdin

Properdin

Diagram of the alternative pathway of complement activation, highlighting the role of properdin.

Properdin is a protein that plays a crucial role in the immune system, specifically in the complement system. It is a positive regulator of the alternative pathway of complement activation, which is one of the three pathways that activate the complement system, an essential part of the innate immune response.

Structure

Properdin is a glycoprotein composed of multiple subunits. It is known to exist in different oligomeric forms, including dimers, trimers, and tetramers. These oligomeric forms are important for its function in stabilizing the alternative pathway convertase complexes.

Function

Properdin functions by binding to and stabilizing the C3 and C5 convertase enzyme complexes of the alternative pathway. This stabilization enhances the activity of these complexes, leading to increased cleavage of complement components C3 and C5, and ultimately, the formation of the membrane attack complex (MAC). The MAC is responsible for lysing pathogens and infected cells.

Role in the Alternative Pathway

The alternative pathway of complement activation is continuously active at a low level, providing a rapid response to pathogens. Properdin is unique among complement proteins because it acts as a positive regulator, enhancing the activity of the pathway. It binds to surfaces of pathogens and damaged cells, promoting the assembly and stability of the C3 convertase (C3bBb) and C5 convertase (C3bBbC3b) complexes.

Clinical Significance

Deficiencies in properdin can lead to increased susceptibility to infections, particularly those caused by Neisseria meningitidis, a bacterium responsible for meningitis. Conversely, excessive activation of the complement system, potentially involving properdin, can contribute to inflammatory diseases.

Research and Therapeutic Potential

Research into properdin and its role in the complement system is ongoing, with potential therapeutic applications in modulating the immune response. Targeting properdin may offer strategies for treating diseases involving complement dysregulation, such as autoimmune diseases and age-related macular degeneration.

Related Pages

• Complement system
• Alternative pathway
• Membrane attack complex
• Neisseria meningitidis